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ABSTRACT
In 2018, of 1.3 million Latinx adults in the United States facing concurrent
issues with substance use disorders (SUD) and mental health disorders (MHD)
93% remained untreated for either diagnosis. This is concerning since Substance
Abuse and Mental Health Services Administration (SAMHSA) data reveals that
this population is at greater risk for suicidal thoughts, plans, and attempts. They
also face structural barriers such as employment, housing, legal involvement,
and insurability that further impede access to treatment.
This study’s purpose was to examine barriers to accessing treatment for
Latinx populations confronting co-occurring SUDs and MHDs. This study used a
qualitative design and data were collected from telephone or zoom interviews
with five Latinxs who identified themselves as dually diagnosed (DD) within the
Inland Empire of Southern California.
This study found that participants reported stigma from the community and
cultural forces as a major barrier to treatment. The study revealed that
participants viewed structural factors such as being uninsured, being
incarcerated, having transportation difficulties, and having work scheduling
difficulties as barriers to treatment. This study also indicated difficulties in
diagnosing a DD, which often led to an inability to consider how one diagnosis
might impact another and ultimately delayed actions to treat a DD.
It is recommended that social workers ensure understanding of unique DD
experiences so they can proactively assess for substance use in early
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adolescence. To address structural barriers, this study recommends universal
access to medical coverage for all individuals, which ultimately foster advanced
preventative interventions for DD individuals.
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CHAPTER ONE
INTRODUCTION

Problem Formulation
As Social Workers enter the professional field they will work with a
multitude of client populations, each of which having varying and competing
needs. The population of focus here will be dual-diagnosed (DD) Black and
Latinx individuals with mental health diagnoses (MHD) and substance use
disorders (SUD). These comorbidities in addition to racial historical trauma and
systematic deprivation for minority populations may complicate treatment
approaches. Clinicians must be aware of the special implications that a DD
entails for this population. This population’s unique social position warrants an
exploration into addressing the psycho-social factors that are applicable, with a
special emphasis on institutional policies such as health care access, legislation,
and criminal justice.
According to the Substance Abuse and Mental Health Services
Administration (SAMHSA) in 2018 there were 1.1 million Black adults who had a
SUD with a co-occurring mental illness, of which 91% received no treatment for
either diagnosis (SAMHSA, 2018a). In that same year 1.3 million Latino adults
had a SUD with a co-occurring mental illness where 93% received no treatment
for either diagnosis (SAMHSA, 2018b). For both populations SUD with cooccurring MHD is associated with higher rates of suicidal thoughts, plans and
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attempts (SAMHSA, 2018a; SAMSA, 2018b). This accounts for about 2.4 million
people who have specific needs that must be met concurrently.
Lo and Cheng (2011) discuss the disparities for minority groups within
healthcare, where often services that are critical for maintaining well-being and
prevention are not provided, which result in higher rates of mortality from
substance treatment related conditions through accidents, relapse and violence
when compared to non-Latinx White populations. The authors explore factors
that increase rates of mortality such as infrequent access to treatment that may
arise from cost of care, lack of insurance coverage, discrimination, mistrust
and/or services that do not provide quality treatment. This study focused on the
type of treatment that individuals accessed, where specialty treatment was
defined as consultation with a substance trained professional (operationalized as
at least several counseling sessions with a psychiatrist, social worker,
psychologist or similarly trained professional and medication management
services). Non-specialty treatment was defined as consultation with a health care
provider not specifically trained in substance or behavioral interventions (Lo &
Cheng, 2011).
The Black population was less likely to report accessing specialty
treatment compared to non-Latinx White populations (Lo & Cheng, 2011). At the
same time, the Black population and Latinx population were more likely to access
non-specialty treatment (Lo & Cheng, 2011). The implications of this are
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important to consider since so few Black and Latino individuals, as noted by
SAMHSA data, seek treatment to begin with.

Purpose of Study
The purpose of this study was geared toward assessing the quality of
treatment services for dual diagnosed Black and Latinx populations in order to
understand what treatment areas could be improved upon. To contextualize the
variability of services, within an analysis of programs meant to treat the DD
population across the United States, only 18% of addiction focused settings and
9% of mental health focused settings were able to provide adequate DD specific
care (McGovern et al., 2014). By studying the efficacy of services, as a means of
finding methods to improve them, it is possible to cultivate greater participation
and trust within treatment programs.
This research was conducted through individual interviews that assessed
community perceptions and barriers to available services. This was necessary in
order to calibrate the study measures to the specific Inland Empire region. By
establishing a clear background of past and/or current treatment access by
participants, there was a better understanding of the community’s perceptions
and needs.

Significance of Study to Social Work
In order to understand how to rehabilitate and reconstitute communities,
research into treatment disparities was necessary. Robbins et al. (2011) found
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that in an analysis of Brief Strategic Family Therapy versus Community-based
Outpatient programs for SUD, Black adolescents had lower rates of engagement
and retention compared to peers across treatment type. Alegria et al. (2011)
notes that disparities in SUD treatment access may be rooted in negative
attitudes towards help-seeking within Black and Latinx communities compared to
non-Latinx White communities. The findings of this research sought to establish
clarity in methods to treat minority communities facing DD comorbidities. Given
the previous research trend it was important to specifically interview the Inland
Empire population on its perceptions to treatment programs.
By engaging in the evaluation phase of the Generalist Intervention Model
this study has been able to get a sense of the Inland Empire’s ability to address
and treat DD individuals. By exploring this topic, this research aimed to pioneer a
revitalized approach to DD treatment outcomes for Black and Latinx populations.
This research is motivated to create a wider array of treatment approaches that
will enable greater access to rehabilitation. This research could be beneficial to
social work students who are in the process of developing their clinical skills. This
research will also allow for discussion and the development of a necessary
awareness of the multimodal approaches needed to holistically treat Black and
Latinx populations. In order to do so, the guiding question was: What are the
barriers to accessing treatment for Black and Latinx populations confronting
SUDs with co-occurring MHD and systemic issues?
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CHAPTER TWO
LITERATURE REVIEW

Introduction
This chapter consists of an investigation of the challenges to reaching
adequate treatment and the issues that develop during this process. The
research is divided into sections where the first portion assessed the psychosocial implications of legislature and in-practice procedures. This is followed with
the section on structural implications of dually diagnosed experiences. The final
subsection discusses the applicability of sociocultural theory and systems theory
for DD Black and Latinx populations.
Psycho-social Implications
Within California after the enactment of Proposition 36 in 2000, a measure
to redirect individuals with substance related offense away from incarceration
and into community-based treatments, a comparison between DD individuals and
their singularly diagnosed substance using counterparts showed an increased
recidivism for DD individuals who had severe mental health diagnoses (Jaffe et
al., 2012). These findings also reported an increased rate of incarceration,
unemployment, unsuccessful substance treatment and rearrests for individuals
who were DD (Jaffe et al., 2012). Without taking Prop 36 into account, the
likelihood of individuals who were DD to initiate and engage in treatment was
less likely for men with schizophrenia and individuals who were actively drug
dependent with recent arrests (Brown et al., 2011). Although positive connection
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and support from family may have aided in initiation and engagement of
substance treatment; severe symptoms, chaotic living circumstances, poor selfcare, poor life functioning, poor symptom management and legal obligations
impacted the ability to seek and engage in treatment (Brown et al., 2011). There
is a need to consider the structural forces (legal obligations, lack of housing,
homelessness, transportation issues and time/schedule requirements) that drive
this population away from service initiation and engagement (Brown et al., 2011).
The psycho-social impact that these inter-dynamic issues illustrate is a highly
complex lived experience that necessitates the ability to actively manage
individuals’ symptomology and behavioral approaches concurrently. Otherwise,
the amount of strain that this interplay has on individuals may very well
exacerbate already present issues; thereby impacting their ability to enroll in
treatment.
Wu and Hser (2011) researched Prop 36 treatment providers and found
that during the initial year only 53% of the workforce was certified as substance
use counselors, additionally of that group only 56% of the certified counselors
(meaning roughly one-fourth of total staff) had a master’s degree or higher
education. The authors note that as funding increased to enrich workforce staff,
the amount of staff that was not certified or that held higher education degrees
remained similar. These types of facilities were the kind that where available to
individuals seeking to initiate services to manage their symptoms. With this
having been the case, the question of whether or not ethical practices were used
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arises. This must be explored since the previously mentioned psycho-social
burdens can lead to an increased difficulty for retention or disengagement.
In a review of 11 guidelines for treating co-occurring substances and
mental illnesses, Perron et al. (2010) found that all guidelines were intended to
be used by medical professionals while of those, only 8 were meant to be used
by behavioral health professionals. Of these 11 guidelines only 2 provided indepth treatment protocols while the others remained vague and open for
interpretations by facilities (Perron et al., 2010). Perron et al. (2010) specifically
drew attention to the differences between American Psychiatric Association
(APA) guidelines for schizophrenia with dual substance use and those for bipolar
disorder, which lacked protocols for co-occurring substance treatment even
though there are higher prevalences for co-occurring substance use for bipolar
disorders. When facilities come across these types of guidelines, which lack
necessary specificity to adequately treat DD populations, there is a danger of
malfeasance in their application.
Although there is research supporting the need for dual diagnoses
treatment integration, the field is still in need of perfecting techniques to reach
larger populations. The role of social workers is to expand the ground leveled
practice to incorporate a more cohesive treatment for DD populations. Further
efforts to do this will likely entail efforts on shifting ideologies surrounding
substance use policies within legislature and the larger social world. Going
further, structural components such as housing, employment, transportation, and
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similar needs will have to be coordinated as part of a holistic dual diagnoses
treatment, especially for systems impacted individuals.
Structural Implications
Veterans with a DD of Post-Traumatic Stress Disorder (PTSD) and SUD
tend to self-medication through illicit substances to lessen the symptoms of
PTSD, which exacerbated their daily functioning by debilitating psycho-social
skills (Owens et al., 2014). Owens et al. (2014) found that veteran groups with
DD (PTSD and SUD) and those with only PTSD and no SUD had higher rates of
depression and avoidant attachments to their peers when compared to groups
diagnosed with only SUD and no PTSD. This suggests that the MHD within DD
groups may be an indication of higher risk to psycho-social functioning issues,
when compared to groups that expressed a singular SUD diagnosis without
MHDs. It is important to explore the interactional effect of multiple diagnoses to
better clinicians’ understandings of treatment approaches, as not doing so would
result in deteriorated psycho-social functioning, specifically in the case of
accessing treatment. In the case of DD alcohol use with anxiety, use of Cognitive
Behavioral Therapy (CBT) to simultaneously treat comorbidities was shown to
reduce alcohol dependencies while having no observable effect on other
substances when comparing to individuals receiving services for a singular
diagnoses of SUD or anxiety (Wolitzky-Taylor et al., 2018). This finding suggests
that addressing the MHD comorbidity while simultaneously addressing the SUD
through psychotherapeutic approaches could have greater impacts in treatment
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methods overall, since the accompanying MHD comorbidity may be driving SUD
behaviors (Wolitzky-Taylor et. al, 2018).
Given the nature of clinical work and the urgency needed to diagnose,
clinicians may elect to focus on SUDs singularly as they may be more apparent.
This could cause negative consequences for clients since there are nuances
within DD MHD and SUD that go beyond the needs of SUD alone. For instance,
Minkoff (2019) discusses the propensity of clinicians to diagnose individuals in
substance related crises with substance-induced disorders instead of properly
investigating client psychiatric histories for information that could lead to more
appropriate care/treatment. Minkoff (2019) asserts the possibility of gathering a
more complete background through analyzing mental states within periods of
sobriety in addition to collateral information so that clinicians may accurately
assess the contexts that triggered the substance related crisis. Temporarily
stabilizing SUDs while leaving obscure MHDs untreated, may lead to cyclical
patterns of relapse and continued SUD, which may only worsen over time.
Mericle et al. (2012) notes that individuals with DD are more likely to have
poorer health, face housing and employment difficulties, and have histories of
suicide attempts. The consequences of improperly diagnosing DD may result in
the loss of social capital within communities. Given the prevalence of substance
use and its effects on marginal social spaces, SUD is a major issue that robs
communities of potential through the loss of unrealized potential from individual
members. This means that in order to holistically address DD within this
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structural setting there must be a re-integrative approach to treatment. Some
aspects of this community re-integration approach are present in an analysis of
SUD on homeless individuals (where homelessness is a structural comorbidity
that affects psychological functioning). Carver et al. (2020) found that the manner
in which treatment interventions were provided made the biggest impact in
increasing the homeless’ likelihood of substance abstinence. Homeless
individuals were able to receive transitional services that ensured their likelihood
to retain homes with basic training in home skills and substance avoidance within
a hospitable and empathetic environment (Carver et. al, 2020).
In a multiracial and ethnic study that assessed Individuals’ co-occurring
disorders of SUD and MHD, Mericle et al. (2012) found that despite White
populations having a higher occurrence of DD SUD and MHD; Black, Latino and
Asian populations with DD SUD and MHD were more likely to be unemployed.
The authors also noted that Black populations were underrepresented in access
to psychiatric hospitalization, noting potential differences in access to care or in
help seeking behaviors as potential explanations for this. Compared to peers
who only had either SUD or MHD, those experiencing DD tend to be more
vulnerable to psychosocial impairments across race and ethnicity (Mericle et al.,
2012). Additionally, most respondents with DD reported that they experienced
symptoms of MHD prior to developing symptoms of SUD, which points toward
the need for SUD prevention as an important treatment objective when
individuals are first treated for early onset MHDs (Mericle et al., 2012).
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In order to understand the DD population’s barriers to treatment more
comprehensively, an intersectional analysis is necessary to dissect the structural
implications of accessing treatment. For example, looking more closely at the
disproportionality of unemployment for minorities with DD should shed light on
structural inequalities, specifically tied to racial and ethnic backgrounds.
Theories Guiding Conceptualization: Sociocultural and Systems Theory
Alegria et al. (2011) proposes a sociocultural framework of health service
disparities through six levels of analysis on 1) federal and economic health care
policies and regulations, 2) operations of the health care system and provider
organization, 3) provider level factors, 4) social and economic forces on
environment, 5) the community system, and 6) client leveled factors in order to
understand the creation and maintenance of health service disparities. This
adaptation of Vygotsky’s Sociocultural theory describes a similar functionality of
cultural influence on an individuals’ functioning within a system, where through
engagement within varying levels of structural components ranging from the
individual to the community to the economic and political levels an individual
learns how to access health care.
Additionally, Systems Theory could be beneficial to provide a schema of
interrelating mechanisms that would illustrate health care functioning. A special
emphasis on the overarching system, subsystems, their relationships and
ascribed roles, inputs and outputs, as well as feedback and interface analysis
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could help to determine where the system is lacking engagement (Zastrow &
Kirst-Ashman, (2016, 2019).

Summary
There is a need to further study treatment disparities within DD Black and
Latino populations due to lacking research in treatment outcomes. The psychosocial barriers in combination with structural barriers further obfuscate the issue.
A detailed examination of various sublevels within the sociocultural framework
serves as a foundation to further explore and understand the system in which
these populations exist. By establishing a consolidated understanding of these
phenomena and reflecting upon it through community input, the next steps in
systemic change will become clearer.
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CHAPTER THREE
METHODS

Introduction
This research explored the perspectives of individuals in seeking and
accessing treatment for DD SUD and MHD. The methods of this analysis are
described in this section. Further discussion on the study design, sampling, data
collection and instruments, procedures, protection of human subjects, and data
analysis follows.

Study Design
The purpose of this study was to explore the factors that affect individual
participation in seeking and accessing treatment for DD SUDs and MHDs
disorders for the Black and Latino populations within the Inland Empire of
Southern California. This was done through the use of qualitative interviews with
participants. Qualitative interviews were chosen in order to allow individuals the
chance to explore the factors that have impacted their access while also
assessing the feelings towards seeking and accessing treatment. Through
collecting the direct experiences of individuals who are missing from the data, the
data collection aided in establishing a necessary foundation of information for the
issue of low treatment access and participation for this population. Through
detailing the direct experiences of individuals, the discourse became client
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centered. This allowed for emphasis on the needs and opinions of individuals as
the guiding framework for future work in addressing treatment gaps.
A limitation to this research was COVID-19’s effects on information
gathering. Individuals may have been less inclined to participate in interviews
with researchers via technological methods due to the lack of human interaction
and discomfort surrounding privacy. Individuals may have been opposed to
online or telephonic interviews with strangers in general. Additionally, locating
participants who fit study criteria proved difficult since individuals may not have
been formally diagnosed. Individuals may not have been aware of applicable
diagnoses that would have made them applicable for study. Participants may
have felt stigmatized and preferred not to participate in research. There may also
have been cultural factors, historical trauma, doubt, or suspicion that inhibited
participation within the research process. In addition, there will be a limitation on
how generalizable the data is to the national population since it was focused on a
small participant pool and specific regional area.
A strength to this research was the ability to contextualize the Inland
Empire’s experiences within the issue of treatment access. With this specific
knowledge it may be possible to better develop methods of attracting Black and
Latinx individuals towards seeking and participating in treatment. In addition to
these benefits, the participants’ insights may be applied to the development of
treatment approaches and interventions. Further research can be developed to
expand the scope of treatment in the future.
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Sampling
The research sample was gathered through purposive and snowball
sampling and consisted of 5 participants who slightly varied in gender identity
and identified as Latinx and were formally or informally diagnosed in having DD
SUDs and MHDs. No individuals that identified as Black participated. Participants
were solicited to contact the researcher if they were interested in participating
through flyers (Appendix D) indicating the type of research to be conducted with
a brief description of qualifications and time needed to participate.

Data Collection and Instruments
IRB approval was granted to conduct qualitative interviews that were
audio-recorded from telephonic or Zoom videoconferencing technologies.
Interviews began with informed consent (Appendix C) and an explanation of the
purpose for the research. The researcher gathered demographic data through a
demographic survey (Appendix A) focused on racial/ethnic identification, gender
identification, age, educational level, geographical background, medical
insurance coverage, annual income, and applicable diagnoses.
Each interview followed the interview guide (Appendix B) that was
available in English and Spanish. The guide was composed of open-ended
questions that focused on eliciting participants’ thoughts and feelings of their
personal experiences. The areas of discussion were individual feelings in
navigating community spaces as a DD individual, family and cultural/community
perceptions of DD experiences and treatment options, and individual or familial
15

support in seeking treatment or other types of assistance. The researcher also
probed further if certain answers were unclear or would benefit from further
explanation.

Procedures
The researcher created a flyer advertising the project with a $10 gift card
incentive to participate, a brief description of the type of study and the
demographic of interest with contact information of the researcher. These flyers
were distributed by Project Rebound at California State University, San
Bernardino that had accepted partnership after IRB approval. The researcher
coordinated around the schedules of participants in order to allow greater access
to interview times. Participants were able to decide what method they preferred
to use, telephone or video call, when signing up. Interviews were done in a 1:1
format. The researcher e-mailed all confidentiality and informed consent
documents to participants in advance of interviews. If email was not a good
method of receiving this documentation, the researcher acquired verbal consent
to participate in the study after reviewing informed consent documents with
participants.
During interviews, the researcher reviewed the informed consent
document and discussed confidentiality to ensure participants were aware of the
information and protocols. The researcher reminded participants that they had
the right to disclose the amount of information they felt comfortable disclosing
and that they had the freedom to resign from the study at any point in time. The
16

researcher took additional notes as participants spoke in order to create a visual
flow chart of ideas and develop content connections. If participants became
upset or distressed during the interview, the researcher paused to assess their
wellbeing and de-escalate with breathing exercises or de-briefing. Once
participants were stable the researcher would ask if they wished to continue and
remind them that they were not obligated to continue. Once interviews were
completed the researcher took the time to assess the participant’s emotional
state and give debriefing statements (Appendix E). The researcher also provided
local resources in case the participant was interested in seeking support or future
services. The researcher thanked the participant for their time and participation.

Protection of Human Subjects
Participants were given pseudonyms upon signing up for the study. After
which the researcher only referred to participants by their pseudonyms in all
forms of communication. Actual names were recorded with pseudonyms in a
physical document that was locked within a case folder. Digital audio recordings
were kept in a password protected flash drive that was locked with physical logs.
Recordings were transcribed with researcher created code names for further
identity protection. Once information was processed it was discussed in broad
categories/charts in order to make re-identification of participants difficult. These
materials will be destroyed 3 years after completion of the study.
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Data Analysis
Demographics variables were analyzed using descriptive statistics. The
interview data was first transcribed chronologically as presented in interviews.
Then the data was analyzed by major and minor themes through a content
analysis process. Individual code names were be created for this transcription
process in order to further remove identifying features. The transcripts included
non-verbal sounds and body language/movements if any were relevant to
dialogue.

Summary
The best approach to understanding perspectives of individuals in seeking
and accessing treatment for dual diagnoses SUDs and MHDs was through
qualitative interviews. Information provided by participants aided to delineate the
work needed for future research and treatment development.
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CHAPTER FOUR
RESULTS

Introduction
This chapter will cover participant demographics and applicable personal
backgrounds. A discussion of major themes involving first use/onset, individual
conceptualization on MHD intersecting with SUD, experiences in treatment
access and use, motivations and barriers toward treatment, DD management
techniques, personal and cultural opinions toward treatment, as well as exploring
support mechanisms.

Findings
Demographics
A total of 5 participants who volunteered for this study met criteria for
research participation. This sample was compromised of 4 self-identified Males
(80%) and 1 self-identified Female (20%). All participants identified as Latinx or a
similar subgroup (such as Chicano, Hispanic, Mexican). No participants identified
as Black or African American.
The median age of participants was 40 years old, with 25 years being the
youngest and 44 years old being the oldest. Two participants ranged from 25-35
years old. Three participants ranged from 36-45 years old. Participant
educational levels were broad with two participants having completed high school
or a high school equivalent, one participant currently in college leveled
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coursework, and two participants with bachelor’s leveled degrees. All participants
lived within the Inland Empire for the last 10 years at time of study. Two
participants had medical insurance through Medi-Cal, two participants had
medical insurance coverage through their employment, and one participant had
no medical insurance. Average annual income was $32,000, ranging from
$12,000 to $55,000 annually.
All participants had a varied history of substance use with accompanying
mental health diagnosis, or characterization of sufficient symptomologies to
warrant identification by individuals. Substance use was classified as problematic
to functioning in order for it to be relevant to study. Substance use varied from
alcohol to stimulants as well as opioids with 80% of individuals (4 participants)
reporting often using more than one type of substance. Two of the participants
experienced neurodevelopmental diagnoses, specifically ADHD and Specified
Learning Disorder. One participant experienced anxiety disorder. The two
remaining participants experienced Schizophrenia spectrum disorders,
specifically Schizoaffective bipolar type and Schizoaffective depressive type.
Initial Onset of Mental Health Disorders and Substance Use Disorders
The average age of substance use was 13.6 years with sixty percent (3)
individuals reporting alcohol as initial substance. On average the participants
reported experiencing their first MHD symptoms at 16.2 years old. Participants
with neurodevelopmental and anxiety disorders experienced early onset of MHD
and SUD when compared to schizophrenic spectrum disorder.
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Neurodevelopmental and anxiety prone individuals experienced MHD at younger
ages from ranging from 8 to 13 years old. This group reported initial substance
use ranging from 10 to 13 years old. Schizophrenic spectrum participants
experienced MHD later in life, with MHD presenting at age 19 and 28. Of this
group, participants began using substances at 22 and 10, respectively. Eighty
percent (4 participants) reported first having a MHD symptom before initiating
substance use.
Historical Conceptualization of Mental Health Disorders and Substance Use
Disorders
Respondents reported a common theme of environmental stressors within
a range of social settings as heavily influencing their substance initiation. For the
three participants (60%) with neurodevelopmental and anxiety disorders,
environmental stressors were predominately school based where academic
performance and social interactions, respectively, caused dysphoria. Two
participants (40%) with schizophrenic spectrum disorders experienced familybased stressors that initiated substance use. Participant 1 explained their first
substance use
Started out smoking pot, thought, it was fun. There was, you know, uh,
from pot it turned to… sniffing paint, it’s just, the experience for me, its
just, I guess it made me, uh, like my… I b- I basically, it just made me feel
numb to where I just… Like, how do you say… suppress my feelings while
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I was still inside? (Participant 1, personal communication, January 14,
2021).
Additionally, two (40%) participants of each group experienced grief from the loss
of a significant family member which caused more serious substance use
frequency as compared to previous self-reported use.
When participants were asked if they felt there were any connection
between MHD and SUD, three participants (60%) in the neurodevelopmental and
anxiety group reported that dysphoric emotions from MHD led into substance
use. For example, Participant 3 reported
When all of my other classmates were acing their tests and stuff that, I
guess it just kinda made me want to just go hang out with the people, you
know, that there were also messing up and those people, those people
were doing like drugs and alcohol (Participant 3, personal communication,
February 18, 2021).
Two participants (40%) with schizophrenic spectrum disorders reported that MHD
symptoms had always been present but that substances made them worse.
When asked about a possible connection between MHD and SUD Participant 4
stated that the MHD was already present but that substances exacerbated it with,
“I really do feel like it got worse, but it didn't, it wasn't determinate- It didn't
determine my mental health” (Participant 4, personal communication, February 9,
2021).
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Treatment of Mental Health Disorders and Substance Use Disorders
In terms of having received treatment, 40% (2 participants) received no
treatment while the remaining 60% (3 participants) received a type of DD
treatment through in-patient services and/or outpatient services. Two participants
(40%) that utilized outpatient DD services who also utilized peer-support groups,
prior to COVID-19’s emergence. Participant 4 expressed how crucial this support
was by stating
Also especially group therapy where others are experiencing the same
problem that you have, that way you can relate to others, and you feel like
you're not the only one, you know, like there's other people going through
this too (Participant 4, personal communication, February 9, 2021).
At time of study all participants reported maintenance of symptom management
with continuation of treatment, if enrolled in treatment. Those that accessed
treatment reported overall pleasant feelings towards care and providers. One
respondent, however, had an instance of negligent care characterized by rapid
and unprecipitated changes to treatment that resulted in serious relapse prior to
being on a stabilized treatment. Participant 1 reported,
I was with one doctor and we had got the medications down, I thought that
I was doing really good. And then, but he retired. then the other doctor
came in and she, from the minute I met her, she was just like, ‘Oh, I know
this. I've been doing this for this many years. And you're on too much of
this and you're on too much of that.’ And she basically like took
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medications away, started prescribing new ones. (Participant 1, personal
communication, January 14, 2021).
Barriers and Facilitators to Treatment
Respondents reported barriers to treatment as: structural limitations, such
as not having insurance and concern over out-of-pocket costs; a need to work in
order to provide for family; feelings of being able to control drug dependencies
through a desire to combat SUD independently; and cultural stigma in accessing
treatment. Participant 2 summarized these conflicting issues with, “providing for
my family, um, having to be, um, placed in a residential setting, um, being away
from my family, um, you know, the job restraints” (Participant 2, personal
communication, January 26, 2021). Participant 5 echoes these sentiments in
explaining their hesitancy for treatment as an uninsured person as “mostly an
economical issue than the desire to seek help.” (Participant 5, personal
communication, February 9, 2021). Additionally, participant 5 reported their
family’s distrust “when it comes to medication for treating mental health and
mental illness.” continuing with, “I think everything to the point of psychiatry is
okay.” (Participant 5, personal communication, February 9, 2021).
Participants stated motivations for seeking treatment to be: fear of losing
family and family support system, having family support in trying to access care
as well as concern for wellbeing, and a desire for self-understanding of
symptoms and their triggers. Participant 3 stated a motivation to change was
rooted in fear of losing their family
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Just losing my family. Like, uh, the fear of like, my family not, is longer, no
longer being there. Losing my kids, not seeing my kids anymore and just, I
don't know just letting my parents down. (Participant 3, personal
communication, February 18, 2021).
For participant 4 structural barriers actually encouraged treatment as they
stated,
I ended up homeless for a while and, um, I was, uh, like I said, I was
misunderstood. I, I slept in parks, I slept, uh, in the street sometimes and
not knowing where I was gonna go. And that’s why most of the time I had
checked myself into one, a hospital so that they can give me hospitality
that I needed too. I was alone. I was on the streets. (Participant 4,
personal communication, February 9, 2021).
Management
Respondents reported varied methods of managing history of DD
symptomologies from the use of prescription medicines to aid dependence, use
of support groups, support from family, and creating changes in behavioral
patterns such as: developing self-regulation skills; avoiding triggers; finding better
methods of coping; and healthy dieting with exercise, even when not enrolled in
treatment. Respondent 3 cited their efforts at keeping away, “from anybody that
was like a trigger. Being around anybody that I knew that gets high or had
anything to get high with, it just made that itch come right back” (Participant 3,
personal communication, February 18, 2021). Participants reported feelings of
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pride and accomplishment with personal development in managing DD. In
reflecting upon this, Participant 5 stated
It was definitely a sense of, I wanna say, almost of pride, you know,
knowing that what once used to be a source of so much stress and
discomfort now, now is only a small shadow of what it used to be”
(Participant 5, personal communication, February 9, 2021).
Perceptions towards Treatment
When asked about their opinions to seeking DD treatment 60% of the
participants (3 participants) reported not having considered the specific type of
treatment. Participant 1 stated, “I never thought about that. I've never really,
honestly, I never been like, presented with anything like that.” (Participant 1,
personal communication, January 14, 2021). Some feelings of reluctance
surfaced for participants who felt they could manage on their own as stated by
Participant 3,
It was the fact, just thinking that I was okay. You know, that, that I had
control of the drugs, not, not the other way around… every time that I
would get out, like I would slowly start using again, like slowly here and
there. And I would go, ‘Well, you know, I, I got it under control. I got it
under control.’ And then by the time that I realized I was already in jail.
(Participant 3, personal communication, February 18, 2021).
Upon reflection, these participants stated that if DD treatment approaches were
available during their initial symptomologies, they might consider them as an
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option to take. The remaining 40% (2 participants) encouraged seeking a DD
treatment, stating they would and did seek such treatment. Participant 4
reported, “I was the type of person that always, you know, was able to seek
medical attention.” (Participant 4, personal communication, February 9, 2021).
As a whole, family perceptions towards seeking treatment were good but
there were some feelings of doubt of respondent’s ability to get treatment,
mistrust in medication use, and fears associated with enrolling in treatment. On a
cultural level, participants reported stigma from their community, shame from
family members, the community’s inability to understand, and overall judgment
against DD individuals. Participant 4 described their community as,
They’re just very judgmental. And, um, that’s where their bottom-line lays,
you know, I don’t think that there’s probably any people out there that give
you that type of— or tries to even give you that type of understanding.
(Participant 4, personal communication, February 9, 2021).
Participant 3 reported similar accounts about their father, “he probably would
have been ashamed” and their close peer group, “my homies, if they would have
known they probably would have been making fun of me, you know, cracking
jokes and stuff” (Participant 3, personal communication, February 18, 2021).
Participant 5 noted that culturally some substances, such as alcohol, are
normalized and even accepted whereas MHD are not. Participant 5 explained
I think culturally substance abuse, given, depending on the substance of
course, it doesn’t carry as much of a social stigma, even not compared to
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mental illness. I think socially there’s more weight on mental illness than,
you know, like in this case, alcohol consumption. So, I don’t see it being a
topic of concern just to seek a dual diagnosis in this case. (Participant 5,
personal communication, February 9, 2021).
Role of Support
Most respondents (60%) cited family support throughout substance use
and dependency stating that parents or siblings had a major influence in always
being present. Participant 2 emphasized the importance of this support with
My parents were, my parents have never left my side. Never ever left my
side. Um, and that, that, that's the reason I think I’m where I am. Where
I'm at today because of them. Um, they didn't, they didn't, they didn't say,
you know what, *washes-hands-off gesture* fix 'em, you know, they didn't,
they didn't have that mindset. You know, they didn't put me in a treatment
center and say, ‘look, we're just leaving you here. Fend for yourself.’ Um,
they were supportive of me throughout the whole, throughout the whole
process, um, you know, going to prison, which my addiction eventually led
me to, um. They stayed, they remained supportive as well (Participant 2,
personal communication, January 26, 2021).
Participant 3 experienced the same level of support
Even my dad as like, he was the last one to find out that I had a drug
problem because I was scared to tell him. He didn’t find out ‘til like the last
time that I got arrested. And I kind of just, as they were taking me in, I kind
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of just told him like, ‘Hey man, I’m messing up, I have a drug problem.
This and that.’ It looked like it hurt him, but I didn’t get the reaction that I
expected from him. You know, I thought I was going to get anger and
shame and maybe even get— maybe even lose like any support that he
had and he was helping me with, you know, but on the contrary, you
know, like I saw a softer side from him, you know, he kinda just stayed
there. You know, even when I was in prison, he would, he would give me
like good letters, you know, and just telling me, like ‘Oh, you know, hope
you’re doing good’ tell me how he couldn’t wait for me to get out and like,
how he was fixing a truck for me to use to start working as soon as I got
out, like, you know, trying to get me back on my feet.” (Participant 3,
personal communication, February 18, 2021).
Other participants (40%) stated that family would attempt to support them but be
unable to completely understand the circumstances.

Summary
This chapter has reviewed participant demographics and their
backgrounds to contextualize the findings. Topics of interest were circumstances
around initial substance use and MHD symptoms, personal understandings of
DD, treatment experiences, motivations and barriers in treatment access,
individual management skills, cultural perceptions of treatment, and supports
available to individuals with DD.
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CHAPTER FIVE
DISCUSSION

Introduction
This chapter will discuss the major findings from chapter 4. Following this
will be the limitations of this study and recommendations for the social work
profession. Recommendations are aimed at addressing social work field practice,
policy advocacy, and academic research. The chapter closes with the
implications of this research and a summary.

Discussion
Stigma
The first major findings center on stigma from the community, where
participants noted that friends and cultural forces would look down upon them or
view them negatively, and how these stigmatizing perceptions made treatment
less preferrable. Participants’ more immediate family seemed to range in support
for treatment from skeptical to accepting. This shows that closer family ties were
less stigmatizing than larger social forces, such as friend groups or neighbors.
This is similar to the work of Alegria (2011) and Lo and Cheng (2011) whose
research stated that negative perceptions of MHD and treatment led to
disinclination to get treatment and worse outcomes. Participant 3 cited their
peers as a source of stigma from ridicule that made them not want to get
treatment even though their partner had recommended they seek and get
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treatment. Participant 4 cited the community’s judgment as a disincentive but
was still able to seek treatment. For participant 4, the community made an impact
but this community was socially more distant than participant 3’s closer peer
group; meaning that the proximity that the social force occupies to the individual
may make a larger difference on the overall effects of stigma.
Lo and Cheng (2011) discussed how these negative perceptions
combined with insufficient care ultimately led individuals to face greater
challenges and higher rates of morbidity. One participant’s experiences of not
having access to treatment and their continued cycle of substance use in this
study showed the ongoing consequences of non-treatment. This situation is
further explained by the stigma this participant’s peer group cast upon him and
the course of action available to him within these circumstances. Another study
finding that not having insurance and concerns over the cost, as well as mistrust
in psychiatric treatment were considered as major factors in never accessing
treatment was also consistent with Lo and Cheng’s (2011) study findings.
Self-medication
The next theme of focus was the role of self-medication through
substance use. This study found that all participants utilized substances to quell
unpleasant MHD symptoms. Participants in the study reported using substances
to ease their unpleasant symptoms and better manage their social environments
through altered states of consciousness. This finding was supported by Owens’
study (2014) that found individuals with PSTD used substances as a method of
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counteracting their PTSD symptoms. Similarly, Following the trend of Owens
(2014), participant psycho-social functioning was also interrupted. This disruption
was evident within the lack of scholastic engagement. Additionally, two
schizophrenia spectrum participants faced psycho-social impairments in the form
of homelessness and isolating behaviors.
This study found that some participants cited the need to develop a sense
of self-understanding and recognizing triggers for substance seeking behaviors.
These actions fall in line with CBT techniques of re-conceptualizing ideas and
developing alternative behaviors that benefit individual’s dysphoric symptoms.
This finding is significant in showing that individuals who have not had access to
treatment may still be able to do the type of self-work necessary to improve their
conditions. Wolitzky-Taylor et al.’s (2018) study explored the capacity for
individuals to reduce their alcohol dependence through the use of cognitive
behavioral therapy (CBT). This intervention trend was seen even with two
participants who did not receive treatment but still managed to initiate the
behavioral changes needed to address their substance dependence.
Identification and Prevention
The following major theme is identification of a DD and how this plays a
role in prevention of ultimately becoming Dually Diagnosed. This study found that
the majority of the participants (60%) that received treatment within clinical
settings were given appropriate diagnoses that guided their treatments. Those
individuals’ treatment plans were ongoing and well maintained. Though histories
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were varied, and different clinical settings were utilized across time, participants
were able to benefit from clear diagnoses that dictated the proper course of
treatment. Minkoff’s (2019) study discussed the importance of clients being
properly diagnosed in clinical settings in order to get appropriate care that
specifically stops cyclic patterns of dysregulation from SUD/DD. These
participants’ success coincides with Minkoff’s (2019) assertion that, although
sometimes complicated, proper diagnosing of applicable MHD and SUD is
crucial. On the contrary, participants that did not engage in treatment were
unaware of their DD status. This meant that these participants saw their MHD as
separate from their SUD. This led to an inability to consider how one diagnosis
may impact the other and ultimately stall any actions to address a DD.
Similarly to Mericle et al. (2012), most participants in the study noted
experiencing MHD before SUD. In these instances, participants reported the
initiation of substances shortly after experiencing MHD or as a method of coping
with their MHD. This is indicative of an important point for individuals to begin
treatment in order to reduce DD severity in the future. Mericle et al. (2012) went
on to state that due to this prevalence of DD, individuals face psycho-social
barriers to employment, housing and the like. Participants within this study
reported an income but did not specify what type of income it was. The
participants’ psycho-social barriers were centered on community settings,
homelessness and navigating social spaces through skill building.
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Structural Considerations
The next theme of focus is the structural intersections to treatment. A half
of the participants in this study discussed the way that some structural factors
such as being uninsured, being incarcerated, having transportation difficulties,
and having job scheduling difficulties contributed to their inability to seek
treatment. This finding is consistent with Brown et al.’s study findings (2011) that
discussed the structural implications, such as legal obligations, job schedule
constraints, transportation, poor self-care, and poor self-management further
complicated access to treatment for DDs. Addressing these types of structural
barriers is an important step in managing a DD and lessening severity of DD
symptoms. These structural factors further complicate individual participation in
treatment, being that seeking treatment may already be a difficult task to initiate
for individuals facing stigma or mistrust. In contrast to this, one participant who
faced homelessness was able to go against the trend and reached out to
services through hospital urgent cares and similar programs in efforts to find
shelter in addition to treatment. This may be an incentive for some of the
population to seek treatment.
Wu and Hser (2011) indicated that substance treatment centers only had
about 50% of staff certified to treat substance use and of about 25% of staff
having a master’s degree or higher to address substance treatment needs. The
participants who were involved in treatment in this study discussed the use of
treatment teams having a medical doctor, therapist, and psychiatrist (if applicable
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to individual needs) or utilizing outpatient services with an established therapist.
Although this is a small sample of participants, the quality of services seemed
adequate for treatment. This is a great benefit in terms of structural resources
available to the participants. Improvements such as these are essential to
provide better standards of care to individuals, especially those with concurrent
diagnoses.
Support as Empowerment
Finally, the socio-cultural approach that Alegria et al. (2011) proposes is
essential to this research study in order to understand the ways that individuals
interface with treatment and their societies. For this study, the model has been
applied in order to focus on the individual, their capabilities, and how those
capabilities intersect within their community’s social forces, with some context
from the upper levels such as provider factors and federal/state policies and
regulations. This is done in order to emphasize the power that individuals hold
within their immediate settings and how these can transcend into larger
mechanisms, through social workers’ mobilization. By harnessing natural
supports in a method that reintegrates individuals into their communities and with
their families, individuals will be able to take initial steps in creating lasting
change. This is seen in the way that participants utilized their familial supports as
motivations and catalysts for treatment and personal development to ultimately
manage their DD symptomologies.
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Limitations
Limitations to this study are the small sample size of 5 participants who
were all Latinx. No participants were identified as Black/ African American. Due
to this the results of this study may not be applicable to the larger population.
This study was conducted during the emergence of COVID-19, which further
complicated research advertisement and participation, as all protocols were
adapted to non-face to face communications such as Zoom or telephone calls.
Another limitation may have been privacy and confidentiality concerns given the
sensitivity and stigma surrounding the topic. Additionally, individuals may not
have been aware of having a dual diagnosis, thereby thinking they would not be
applicable for participation. Another consideration is that the qualifications for
meeting a dual diagnosis may be too broad due to the researcher’s inability to
formally diagnose individuals as a Master of Social Work student.

Recommendations for Practice, Policy, and Research
Given that most individuals in this study had MHD symptoms before
initialing substance use and they stated the MHD as the reason or a link to
beginning to use substances, it is highly recommended that micro-leveled social
workers proactively assess for substance use for adolescents. This means that
micro-leveled social workers must understand the intricacies of concurrent MHD
and SUD, even before such dual diagnoses become apparent. Mimicking the
way that risk assessments are preformed may be a good initial response to start
assessing for substance use, with a special emphasis on concurrent MHDs.
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Educating and/or providing social workers and social work students trainings on
the intricacies of concurrent diagnoses would also be an important step for early
detection and prevention of DD. This focus can be applied within university
settings as an educational requirement that designates a set period of time to
study. Social workers can also seek to develop new specialized treatment
interventions for DD.
Within community settings, social workers can work to eliminate the
stigma on MHDs while simultaneously increasing awareness on the prevalence
of SUDs. By stressing the complexity of a DD, social workers can educate the
general population on how MHDs and SUDs can co-occur and what this DD
means for quality of life. Once the general population is more aware of DDs,
individuals may feel more comfortable in seeking treatment.
On a policy (macro) level, social workers should seek to expand access to
medical coverage for all individuals as a human right. These efforts would
complement micro leveled approaches previously stated as more advanced
preventative interventions. If all individuals have the options for treatment through
medical insurance coverage presented to them to access treatment, some of the
structural barriers that participants discussed would be alleviated. This would
also enhance the overall wellbeing and health of individuals, which strongly
impact mental well-being.
Overall further research should be conducted with larger samples to get a
better understanding of areas of improvement for treatment access. This
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research would also aid in enabling social workers to better understand what it
means to work with and treat dual diagnoses properly. Research could also help
to guide the creation of a new intervention approach. A specific area of focus for
the research to expand upon would be the specific policies that have shaped the
health care system in respect to accessing specialized treatments. Findings here
could provide insights for politicians and macro leveled social workers to create
beneficial legislation for individuals with dual diagnoses.

Conclusion
This chapter covered the role of stigma in treatment, the role of selfmedication and how that may hinder individuals’ wellbeing, the importance of
identification and prevention of DD, structural implications for treatment access,
and the role of social supports. Limitations were discussed and
recommendations for social workers in micro, macro and academic arenas were
proposed.
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APPENDIX A
DEMOGRAPHIC SURVEY
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1) Race/Ethnicity:
Raza / Etnicidad:
2) Gender identity:
Identidad de género:
3) Age/ Edad: ___ 18-25; ___ 26-33; ___ 34-41; ___ 42-49; ___ 50+
4) Educational level:
Nivel educacional:
5) Geographical area:
Zona geográfica
6) Medical insurance:
Seguro médico
7) Annual income range:
Ingresos anuales:
8) Diagnosis of substance disorder and mental health disorder:
Diagnóstico de trastorno por sustancias y trastorno de salud mental:
Developed by Pedro Bañuelos
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APPENDIX B
INTERVIEW GUIDE
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1) What was your first instance of a SUD/MHD? Around what age did it start?
What life events were happening during that time?:
¿Cuál fue su primera instancia de un SUD / MHD? ¿Alrededor de qué edad
empezó? ¿Qué eventos de la vida sucedieron durante ese tiempo ?:
2) Have you ever thought about a connection between SUD and MH? Have
you ever thought they might be related?
¿Ha pensado alguna vez en una conexión entre SUD y MH? ¿Alguna vez
pensaste que podrían estar relacionados?
3) What would you think/feel about seeking treatment for Dual Diagnosis (of
substance use disorder/mental health disorders)?
¿Qué pensaría / sentiría acerca de buscar tratamiento para el diagnóstico
dual (de trastorno por uso de sustancias / trastornos de salud mental)?
4) Have you ever received treatment before? What was your experience like?
¿Ha recibido tratamiento antes? ¿Cómo fue tu experiencia?
5) What things would stop you from looking for treatment? What would make
you want to look for treatment?
¿Qué cosas le impedirían buscar tratamiento? ¿Qué te haría querer buscar
tratamiento?
6) How have you managed or gone about dealing with DD so far? How has
that felt? What kind of emotions or body sensations have you felt
specifically?
¿Cómo ha manejado o ha hecho frente al diagnóstico dual hasta ahora?
¿Cómo se ha sentido eso? ¿Qué tipo de emociones o sensaciones
corporales has sentido específicamente?
7) What are your family’s feelings or thoughts towards seeking treatment?
¿Cuáles son los sentimientos o pensamientos de su familia hacia la
búsqueda de tratamiento?
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8) What would your culture or community think if you sought out treatment for
dual diagnoses?
¿Qué pensaría su cultura o comunidad si buscara tratamiento para el
diagnóstico dual?
9) Has your family supported or helping you manage a dual diagnosis?
¿Su familia lo ha apoyado o ayudado a manejar un diagnóstico dual?
Developed by Pedro Bañuelos
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APPENDIX C
INFORMED CONSENT
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INFORMED CONSENT
The study that you are invited to participate in is designed to explore factors that affect
participation in seeking and accessing treatment for dual diagnosed substance use
disorders (SUDs) and mental health disorders (MHDs) of the Black and Latino
populations within the Inland Empire of Southern California. This study is being
conducted by Pedro Bañuelos, a graduate student, under the supervision of Dr. Janet
Chang, Professor in the School of Social Work at California State University, San
Bernardino (CSUSB). This study has been approved by the Institutional Review Board at
CSUSB.
PURPOSE: The purpose of this study is to understand the seeking and access of
treatment for dual diagnosed SUDs and MHDs among Black and Latino populations.
DESCRIPTION: Participants will be interviewed on their experiences in seeking and
accessing treatment, thoughts on treatment approaches, barriers to treatments, supports
for treatment, thoughts on ways to make treatment sound like better alternative.
PARTICIPATION: Your participation in this study is completely voluntary and you may
refuse or discontinue your participation at any time without any consequences.
CONFIDENTIALITY: Your responses will be confidential, and data will be reported by
population observations.
DURATION: The interview will be 45 minutes to 1 hour in length.
RISKS: No risks are anticipated but certain individuals may feel complex emotions from
talking about such personal topics and experiences. Participants do not have to answer
if they do not wish to, may skip a question or end their participation at any time.
BENEFITS: No direct benefits are expected for participants. Participants may be able to
reflect on their medical care and gain an understanding of barriers. Study findings will
help to develop a better understanding of this area of research.
CONTACT: If you have any questions about this study, please feel free to contact Dr.
Janet Chang at (909) 537-5184.
RESULTS: Results of the study can be obtained from the Pfau Library ScholarWorks
database
(http://scholarworks.lib.csusb.edu/) at California State University, San Bernardino after
July 2021.
***************************************************************************************************
I agree to have this interview be audio recorded: _____ YES _____ NO
I understand that I must be 18 years of age or older to participate in your study, have
read and understand the
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consent document and agree to participate in your study.

________________________________
Place an X mark here

_____________________
Date
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CONSENTIMIENTO INFORMADO
El estudio en el que está invitado a participar está diseñado para explorar los factores
que afectan la participación en la búsqueda y el acceso al tratamiento para los
trastornos por uso de sustancias (TUS) y los trastornos de salud mental (MHD) de
diagnóstico dual de las poblaciones negras y latinas dentro del Inland Empire of
Southern California. Este estudio está siendo realizado por Pedro Bañuelos, un
estudiante de posgrado, bajo la supervisión de la Dra. Janet Chang, Profesora de la
Escuela de Trabajo Social de la Universidad Estatal de California, San Bernardino
(CSUSB). Este estudio ha sido aprobado por la Junta de Revisión Institucional de CSUSB.
Propósito: El propósito de este estudio es comprender la búsqueda y el acceso al
tratamiento para los TUS y MHD de diagnóstico dual entre las poblaciones negras y
latinas.
Descripción: Se entrevistará a los participantes sobre sus experiencias en la búsqueda
y acceso al tratamiento, pensamientos sobre enfoques de tratamiento, barreras a los
tratamientos, apoyos para el tratamiento, y pensamientos sobre formas de hacer que el
tratamiento parezca una mejor alternativa.
Participación: Su participación en este estudio es completamente voluntaria y puede
rechazar o interrumpir su participación en cualquier momento sin consecuencias.
Confidencialidad: Sus respuestas serán confidenciales y los datos del estudio se
informarán mediante observaciones de la población.
Duración: La entrevista tendrá una duración de 45 minutos a 1 hora.
Riesgos: No se anticipan riesgos, pero ciertas personas pueden sentir emociones
complejas al hablar sobre temas y experiencias tan personales. Los participantes no
tienen que responder si no lo desean, pueden saltarse una pregunta o finalizar su
participación en cualquier momento.
Beneficios: No se esperan beneficios directos para los participantes. Los participantes
pueden reflexionar sobre su atención médica y comprender las barreras. Los resultados
del estudio ayudarán a desarrollar una mejor comprensión de esta área de
investigación.
Contacto: Si tiene alguna pregunta sobre este estudio, comuníquese con la Dra. Janet
Chang al (909)537-5184.
Resultados: Los resultados del estudio se pueden obtener de la base de datos
ScholarWorks de la biblioteca de Pfau. (http://scholarworks.lib.csusb.edu/) en la
Universidad Estatal de California, San Bernardino después de julio de 2021.
****************************************************************************************************
Acepto que esta entrevista se grabe en audio: _____ Si _____ No
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Entiendo que debo tener 18 años o más para participar en su estudio, haber leído y
comprendido el
documento de consentimiento y acepta participar en su estudio.
____________________________________
Coloque una marca X aquí
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_____________________
Fecha

APPENDIX D
RESEARCH FLIER
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APPENDIX E
DEBREIFING STATEMENT
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This study you have just completed was designed to learn more about accessing care for
dual diagnosed individuals. By participating you may have discussed difficult topics to
process, so the researcher would like to offer local services that may be useful. Please
reach out to these if needed:
Este estudio que acaba de completar fue diseñado para obtener más información sobre el
acceso a la atención para personas con diagnóstico dual. Al participar, es posible que
haya hablado sobre temas difíciles de procesar, por lo que al investigador le gustaría
ofrecer servicios locales que pueden ser útiles. Comuníquese con estos si es necesario:

San Bernardino County/ Condado de San Bernardino
Crisis Stabilization/ Estabilización de crisis
• Windsor Center
Crisis Stabilization Unit – A, ADS, C, F, MH, P
(view legend)
1481 N. Windsor Drive
San Bernardino, CA
Ph: (909) 361-6470 or 7-1-1 for TTY Users
Hours of Operation: 24 hours a day, 7 days a week/ Horas de operación: 24 horas
al día, 7 días a la semana
•

Merrill Center
Crisis Stabilization Unit – A, ADS, C, F, MH, P
(view legend)
14677 Merrill Ave
Fontana, CA
Ph: (951) 643-2340 or 7-1-1 for TTY Users
Hours of Operation: 24 hours a day, 7 days a week/ Horas de operación: 24 horas
al día, 7 días a la semana

Recovery Based Engagement Support Team (RBEST) provides community outreach,
engagement, case management, family education, support, and therapy
(909) 421-9452
El equipo de apoyo a la participación basada en la recuperación (RBEST)
proporciona alcance comunitario, participación, gestión de casos, educación familiar,
apoyo y terapia (909) 421-9452
Detox Services
Servicios de desintoxicación
•

Cedar House Life Change Center
18612 Santa Ana Ave.
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Bloomington, CA 92316
Phone: (909) 421-7120
•

Inland Valley Recovery Services
Upland Recovery Center
1260 Arrow Highway
Bldg. C
Upland, CA 91786
Phone: (909) 932-1069

Recovery centers – classes and sober living support
Centros de recuperación: clases y apoyo para una vida sobria
• Inland Valley Recovery Services
San Bernardino Recovery Center
939 North D Street
San Bernardino, CA 92410
Phone: (909) 889-6519
•

Inland Valley Recovery Services
Upland Recovery Center
934 N. Mountain Ave.
Suites A & B
Upland, CA 91786
Phone: (909) 949-4667

•

MHS Central Valley Regional Recovery Center
1076 Santo Antonio Drive
Suite B
Colton, CA 92324
Phone: (909) 433-9824

•

St. John of God
Hospitality Center
15534 6th Street
Victorville, CA 92393
Phone: (760) 952-9192

Riverside County/ Condado de Riverside
Crisis Stabilization/ Estabilización de crisis
• 9990 County Farm Road, Ste. 4
Riverside, CA 92503
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Phone: (951) 358-4881
Se Habla Español
•

85 Ramona Expressway, Suites 1-3
Perris, CA 92571
951-349-4195 Main

•

Blaine Street Adult Clinic
769 Blaine Street, Suite B Riverside, CA 92507
Phone: (951) 358-4705
Fax: (951) 358-4719

•

Hemet Mental Health Clinic
650 North State Street
Hemet, CA 92543
Phone: (951) 791-3300

Substance Use Community Access, Referral, Evaluation, and Support (SU CARES)
Line: (800) 499-3008
Línea de acceso, derivación, evaluación y apoyo de la comunidad para el uso de
sustancias (SU CARES): (800) 499-3008
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APPENDIX F
INSTITUTIONAL REVIEW BOARD APPROVAL
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